Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Anim Reprod Sci ; 70(3-4): 235-49, 2002 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-11943493

RESUMO

In our study, we observed the activation of in vitro matured pig oocytes and their subsequent parthenogenetic cleavage after stimulation of ryanodine receptors (RyR) using ryanodine (Ry), caffeine or cyclic adenosine diphosphate ribose (cADPri) or after stimulation of inositol triphosphate receptors (IP(3)R) using D-myo-inositol 1,4,5-triphosphate (IP(3)). Heparin, a potent blocker of IP(3)R, prevented the activation of porcine oocytes using IP(3), but blockers of RyR (ruthenium red or procaine) prevented activation after stimulation by RyR and stimulation by IP(3)R using IP(3). The drugs were injected into oocytes matured to the stage of metaphase II and activation was determined by assessment of pronuclear formation. The activity of H1 kinase was determined and our results demonstrated a significant drop in H1 activity in the activated oocytes. The cleavage of parthenogenetic embryos progresses to more advanced stages after stimulation by IP(3)R than after stimulation by RyR. Our results could indicate that, in pig oocytes, the calcium released from IP(3)-sensitive stores triggers the calcium release from ryanodine-sensitive intracellular stores, which is necessary for oocyte activation. The calmodulin inhibitors ophiobolin A and W7 reduce the activation of oocytes induced by stimulation of RyR or IP(3)R.


Assuntos
Adenosina Difosfato Ribose/análogos & derivados , Inositol 1,4,5-Trifosfato/metabolismo , Oócitos/efeitos dos fármacos , Oócitos/fisiologia , Canal de Liberação de Cálcio do Receptor de Rianodina/efeitos dos fármacos , Suínos/fisiologia , Adenosina Difosfato Ribose/farmacologia , Animais , Cafeína/farmacologia , Cálcio/metabolismo , Canais de Cálcio/efeitos dos fármacos , Calmodulina/antagonistas & inibidores , Calmodulina/fisiologia , Núcleo Celular/ultraestrutura , ADP-Ribose Cíclica , Feminino , Heparina/farmacologia , Inositol 1,4,5-Trifosfato/farmacologia , Receptores de Inositol 1,4,5-Trifosfato , Metáfase , Microinjeções , Oócitos/ultraestrutura , Partenogênese , Receptores Citoplasmáticos e Nucleares/efeitos dos fármacos , Rianodina/farmacologia , Canal de Liberação de Cálcio do Receptor de Rianodina/fisiologia
2.
J Exp Zool ; 287(4): 304-15, 2000 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-10951390

RESUMO

Cyclopiazonic acid (CPA), a potent inhibitor of endogenous calcium-dependent ATPases, is able to induce parthenogenetic activation in pig oocytes matured in vitro. Sixty-four percent of matured pig eggs cultured with 100 nM CPA for 4 hr were activated. A similar activation rate was observed in oocytes treated with thapsigargin, another inhibitor of calcium-dependent ATPases. The parthenogenetic development of CPA-activated eggs did not proceed beyond the 8-cell stage. The blockage of calcium channels by verapamil only slightly decreased the proportion of CPA-activated pig oocytes. This indicates that the release of calcium from intracellular stores is sufficient for oocyte activation and calcium influx from extracellular sources has no significant role. The significant decrease in CPA-activated oocytes (100 nM of CPA for 4 hr) after a microinjection of heparin indicated that the mobilization of intracellular calcium stores is mediated through inositol trisphosphate receptors. On the other hand, the only slightly depressed activation rate in oocytes microinjected with ruthenium red and procaine indicates that CPA mobilizes a much smaller amount of calcium through the ryanodine receptors. The marked inhibitory effect of ophiobolin A and W7 on the activation of CPA-treated pig oocytes suggests that the calcium signal, as the second messenger, acts downstream through calmodulin. J. Exp. Zool. 287:304-315, 2000.


Assuntos
ATPases Transportadoras de Cálcio/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Indóis/farmacologia , Oócitos/efeitos dos fármacos , Partenogênese/efeitos dos fármacos , Suínos/fisiologia , Animais , Cálcio/metabolismo , Canais de Cálcio/efeitos dos fármacos , Canais de Cálcio/metabolismo , Células Cultivadas , Feminino , Heparina/farmacologia , Receptores de Inositol 1,4,5-Trifosfato , Microinjeções , Oócitos/fisiologia , Oócitos/ultraestrutura , Partenogênese/fisiologia , Procaína/farmacologia , Receptores Citoplasmáticos e Nucleares/efeitos dos fármacos , Receptores Citoplasmáticos e Nucleares/metabolismo , Rutênio Vermelho/farmacologia , Sesterterpenos , Sulfonamidas/farmacologia , Terpenos/farmacologia , Tapsigargina/farmacologia , Verapamil/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA